Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dipna Pharmachem has informed that meeting of the Board of Directors of the Company held on Friday, 15th December, 2023 at the Registered Office of the Company which commenced at 5:00 pm and concluded at 6:30 pm has considered and approved: Appointment of Madhuri Gurwani as Company secretary (CS) and Compliance Officer (CO) of the Company with effect from 15th December, 2023. The details required under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No CIR/CFD/CMD/4/2015 dated 09/09/2015 are given in Annexure A.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Redington | 227.35 |
| Adani Enterprises | 2225.25 |
| Amrapali Industries | 17.27 |
| Rashi Peripheral | 474.40 |
| PDS | 291.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: